OS Therapies (NYSE: OSTX) is a cancer immunotherapy company engaged in the development of new treatments for osteosarcoma and other solid tumors.
OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness
News
Categories
News
MKC Earnings: All you need to know about McCormick & Company’s Q1 2025 earnings results
McCormick & Company, Incorporated (NYSE: MKC) reported its first quarter 2025 earnings results today. Net sales of $1.61 billion remained relatively unchanged
KBH Earnings: KB Home Q1 profit drops on lower sales, misses estimates
Homebuilder KB Home (NYSE: KBH) on Monday announced financial results for the first quarter of 2025, reporting lower revenues and profit. The
Can Nike (NKE) achieve sustainable growth under new leadership?
Nike, Inc. (NYSE: NKE) is banking on innovations in its product portfolio and improvements in the operating environment to regain strength, while
Here’s how Lennar (LEN) is navigating a challenging macroeconomic environment
Shares of Lennar Corporation (NYSE: LEN) gained over 1% on Monday. The stock has dropped 11% over the past three months. The
KB Home Q1 2025 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript
Homebuilder KB Home (NYSE: KBH) will publish its first-quarter 2025 financial results today after the closing bell. Analysts forecast a year-over-year increase
NKE Q3 Call Highlights: Inventory Overhaul, Premium Push, and China Challenges!
Nike Inc., the world's largest supplier of athletic shoes and apparel and a major manufacturer of sports equipment, in its Q3 earnings
Micron (MU) projects record Q3 revenue, powered by strong HBM sales
Micron’s (NASDAQ: MU) second-quarter report underscores its leadership position in high-bandwidth memory (HBM) chips and AI-driven data center solutions. The expanding portfolio
FedEx (FDX): Uncertain demand environment and inflationary pressures dampen outlook
Shares of FedEx Corp. (NYSE: FDX) were down 6% on Friday after the company reported its earnings results for the third quarter
NKE Earnings: Nike reports lower sales for Q3 2025
NIKE, Inc. (NYSE: NKE) has reported a decline in earnings for the third quarter of 2025, hurt by a slowdown in sales
NIO Infographic: A snapshot of Nio’s Q4 2024 earnings report
China-based electric car maker NIO Inc. (NYSE: NIO) on Friday reported a net loss for the fourth quarter of 2024. Revenues increased
CCL Infographic: Carnival Corp. swings to adjusted profit in Q1 on higher revenues
Carnival Corporation & plc. (NYSE: CCL) Friday reported an increase in revenue for the first quarter of 2025. The cruise line operator
Lennar Corporation (LEN) Earnings: 1Q25 Key Numbers
Lennar Corporation (NYSE: LEN) reported total revenues of $7.6 billion for the first quarter of 2025 compared to $7.3 billion in the
Infographic: How FedEx (FDX) performed in Q3 2025
FedEx Corp. (NYSE: FDX) reported revenue of $22.2 billion for the third quarter of 2025, up 2% compared to the same quarter
MU Q2 Call Highlights: HBM Boom, Margin Gains, and AI-Driven Growth!
Micron Technology Inc., an American producer of computer memory and data storage solutions, including DRAM, flash memory, and SSDs, in its Q2
MU Earnings: Micron Q2 profit jumps on higher revenues, tops expectations
Semiconductor company Micron Technology Inc. (NASDAQ: MU) Thursday reported a sharp increase in revenues and earnings for the second quarter of 2025.
Darden Restaurants sees growth in FY25 and beyond amid menu, tech Innovations
Darden Restaurants, Inc. (NYSE: DRI) has successfully navigated the challenging market environment by constantly innovating its menu offerings and fostering customer loyalty.
What to look for when McCormick & Company (MKC) reports Q1 2025 earnings
Shares of McCormick & Company, Incorporated (NYSE: MKC) were down 1% on Thursday. The stock has gained 5% year-to-date. The spice giant is slated
Micron Q2 2025 Earnings Call: Listen Live and Follow Along with the Real-Time Transcript
Memory chipmaker Micron Technology Inc. (NASDAQ: MU) will report its second-quarter 2025 results today after regular trading hours. Listen to Micron’s Q2
Earnings Summary: Quest Diagnostics (DGX) reaffirms FY25 guidance
Quest Diagnostics Incorporated (NYSE: DGX), a provider of diagnostic information services, has reaffirmed its outlook for fiscal 2025 and provided cautious first-quarter
Earnings Summary: A snapshot of FactSet’s Q2 2025 report
FactSet Research Systems Inc. (NYSE: FDS), a leading provider of data analytics services, on Thursday announced financial results for the second quarter